Skip to content

Evaluating the Feasibility and Reliability of Using Handheld Nebulizers to Conduct Cough Sensitivity Testing With Citric Acid

Evaluating the Feasibility and Reliability of Using Handheld Nebulizers to Conduct Cough Sensitivity Testing With Citric Acid

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07531901
Enrollment
10
Registered
2026-04-15
Start date
2026-07-15
Completion date
2027-02-28
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough Reflex Sensitivity

Keywords

cough challenge testing, cough reflex sensitivity testing

Brief summary

Objective cough reflex sensitivity testing is typically restricted to specialized research laboratories due to reliance on expensive dosimeter-controlled aerosol delivery systems. This study evaluates the feasibility and reliability of a low-cost alternative method using a handheld nebulizer for citric acid cough challenge testing. Healthy adult participants will complete cough reflex sensitivity testing using both a standard dosimeter-controlled nebulizer system (Cosmed QuarkSpiro) and a handheld nebulizer (DeVilbiss 45). The study will compare cough threshold outcomes between methods to determine whether handheld nebulizer-based testing produces comparable and reproducible measurements.

Detailed description

Cough reflex sensitivity testing is widely used in respiratory research to quantify airway sensory responsiveness. Traditional testing protocols use dosimeter-controlled nebulizer systems to deliver precise concentrations of aerosolized tussive agents such as citric acid. However, these systems are costly and require specialized laboratory infrastructure, limiting access to objective cough testing in outpatient and community-based settings. This study investigates the feasibility and reliability of using a commercially available handheld nebulizer as a low-cost alternative for cough reflex sensitivity testing. Healthy adult volunteers will undergo standardized cough challenge testing using citric acid delivered through two aerosol delivery systems: a laboratory dosimeter-controlled nebulizer (Cosmed QuarkSpiro) and a handheld nebulizer (DeVilbiss 45). The primary outcomes will be cough threshold measures (e.g., C2 and C5), defined as the citric acid concentration that elicits two or five coughs. Participants will complete testing sessions using both delivery methods under controlled conditions. Findings from this proof-of-concept study will inform future research aimed at expanding access to objective cough assessment in clinical and community settings.

Interventions

DEVICECosmed QuarkSpiro Dosimeter-Controlled Nebulizer

Laboratory spirometry system equipped with a dosimeter-controlled nebulizer used to deliver standardized aerosolized citric acid during cough challenge testing.

DEVICEDeVilbiss 45 Handheld Nebulizer

Commercial handheld nebulizer used to deliver aerosolized citric acid during cough challenge testing.

Sponsors

University of Montana
Lead SponsorOTHER
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Healthy adult participants will complete cough sensitivity testing using two aerosol delivery systems.

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults at least 18 years of age * Consent to audio/video recording of the research sessions for research purposes * Spirometry testing results obtained by study team on same day of first testing session with FEV1/FVC ratio and FEV1 percent predicted values of at least 0.70

Exclusion criteria

* Pregnant or trying to become pregnant (if capable of becoming pregnant- a urine pregnancy test will be provided onsite and a negative result must be obtained prior to the first testing session) * Smoking of any substance in the last six months * Diagnosed or suspected pulmonary disease (e.g., asthma, COPD) * History of chronic cough * History of head or neck cancer * History of neurological disease (e.g., cerebrovascular accident) * History of dysphagia (swallowing difficulty) * Current complaint of a voice problem * Current upper respiratory infection

Design outcomes

Primary

MeasureTime frameDescription
Test-retest reliability of the concentration of citric acid that elicits two or more coughs (C2)Cough sensitivity testing to determine cough thresholds (C2) will be performed at each of four weekly study visits, with visits occurring every 7 days across a 4-week study period.The test-retest reliability (Intraclass correlation coefficient) of the citric acid concentration required to elicit two coughs during cough challenge testing will be evaluated and compared for each testing method.
Test-retest reliability of the concentration of citric acid that elicits five or more coughs (C5)Cough sensitivity testing to determine cough thresholds (C5) will be performed at each of four weekly study visits, with visits occurring every 7 days across a 4-week study period.The test-retest reliability (Intraclass correlation coefficient) of the citric acid concentration required to elicit five coughs during cough challenge testing will be evaluated and compared for each testing method.

Countries

United States

Contacts

CONTACTJane E Salois, PhD
jane.salois@umontana.edu406-243-2138
CONTACTLaurie J Slovarp, PhD
laurie.slovarp@umontana.edu406-243-2107

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026